Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Chief Accounting Officer | March 08, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date March 08, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 183,061 |
Ending reported balance
After 2026-03-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-08 · Exercise / conversion · Acquired 10,201 · Balance 185,949 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2026-03-08 · Tax withholding · Disposed 4,201 · Balance 181,748 Row 3 · 2026-03-08 · Exercise / conversion · Acquired 2,233 · Balance 183,981 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 4 · 2026-03-08 · Tax withholding · Disposed 920 · Balance 183,061 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 20,402 |
Reported balance
After 2026-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-08 · Exercise / conversion · Disposed 10,201 · Balance 20,402 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 17,858 |
Reported balance
After 2026-03-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-08 · Exercise / conversion · Disposed 2,233 · Balance 17,858 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,205 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 808 | $4.61 | $3,724.88 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,874 Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,191 | $4.61 | $19,320.51 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,449 Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 114,507 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,507 Underlying: Class A Common Stock · 114,507 shares Expires 2035-03-05 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on May 15, 2025 with the remaining 93.75% underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 76,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,866 Underlying: Class A Common Stock · 76,866 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,965 Underlying: Class A Common Stock · 12,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 5,202 | $4.84 | $25,177.68 |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,439 Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,071 | $4.15 | $4,444.65 |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,979 Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,020 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,406 Underlying: Class A Common Stock · 10,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 797 | $4.91 | $3,913.27 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,444 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,640 | $4.91 | $17,872.40 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,009 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,627 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,519 | $5.04 | $22,775.76 |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,449 Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| October 15, 2024 Filed Oct 18, 2024 17:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000183 · wk-form4_1729287417.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,606 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| October 15, 2024 Filed Oct 18, 2024 17:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 930 | $6.91 | $6,426.30 |
DisclosureSEC source: 0001809519-24-000183 · wk-form4_1729287417.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,305 Read SEC document |
| October 15, 2024 Filed Oct 18, 2024 17:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000183 · wk-form4_1729287417.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,252 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,606 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 797 | $7.71 | $6,144.87 |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,629 Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,640 | $7.71 | $28,064.40 |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,194 Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 20:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000179 · wk-form4_1725926460.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 16:40 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 79,000 | $6.77 | $534,624.60 |
DisclosureSEC source: 0001809519-24-000169 · wk-form4_1723668044.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,633 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.705 to $6.865, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000166 · wk-form4_1723151676.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,290 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,519 | $8.61 | $38,908.59 |
DisclosureSEC source: 0001809519-24-000166 · wk-form4_1723151676.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,633 Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000166 · wk-form4_1723151676.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 15, 2024 Filed Jul 15, 2024 18:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000149 · wk-form4_1721082358.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,212 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| July 15, 2024 Filed Jul 15, 2024 18:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 930 | $7.71 | $7,170.30 |
DisclosureSEC source: 0001809519-24-000149 · wk-form4_1721082358.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,489 Read SEC document |
| July 15, 2024 Filed Jul 15, 2024 18:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000149 · wk-form4_1721082358.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,484 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,807 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 797 | $8.55 | $6,814.35 |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,813 Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,640 | $8.55 | $31,122.00 |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,378 Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 19:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000108 · wk-form4_1718060565.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 08, 2024 Filed May 8, 2024 17:48 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000075 · wk-form4_1715204869.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,953 Underlying: Class A Common Stock · 12,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 08, 2024 Filed May 8, 2024 17:48 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,518 | $7.53 | $34,020.54 |
DisclosureSEC source: 0001809519-24-000075 · wk-form4_1715204869.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,817 Read SEC document |
| May 08, 2024 Filed May 8, 2024 17:48 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000075 · wk-form4_1715204869.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 17:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000053 · wk-form4_1713303479.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,818 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 17:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 930 | $6.83 | $6,351.90 |
DisclosureSEC source: 0001809519-24-000053 · wk-form4_1713303479.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,673 Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 17:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000053 · wk-form4_1713303479.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.